Google Found Its Nuclear Power. NuScale Still Can’t Find a Customer.
A 22-year Finnish reactor deal and a brutal UBS downgrade define the two sides of the nuclear trade investors must…
Copper at $6.45 After the Record Drop. Here Is What Traders Watch Monday.
The White House still has no decision on refined copper tariffs, and that uncertainty is now the only price that…
Copart Paid $1.9 Billion Because Insurance Volume Told It To
Its biggest acquisition ever makes sense once you see the volume problem hiding inside a quarterly beat.
Saudi Arabia Just Lost Its Role as Oil’s Emergency Valve
With output at a 36-year low and export routes constrained, oil dips are opportunities to buy, not invitations to fade.
Brent Is Above $101. Novorossiysk Is the Risk Wall Street Misprices.
Ukraine’s strike adds a different supply risk than US-Iran tensions, and the market is treating them as interchangeable.
A Pill Just Matched Injectable HAE Drugs in Phase 3
Pharvaris hit every endpoint and BCRX dropped 9%. The asymmetry now favors defined-risk positions on the incumbents.
Novartis Bought a Platform. The Lead Drug Just Failed. Now What?
The del-desiran miss raises a question large-cap pharma investors dodge: how much of a share price is pipeline hope, and…
Expedia and Booking’s Big Drop Is Not About Fuel Costs
When travel sells off with no company news, crude is hitting demand next.
Tradeweb Processed $61 Trillion in August. Bond Chaos Is Its Business.
When yields swing and portfolios reposition, Tradeweb collects a fee on every trade, and August’s data shows how durable that…
SoftBank’s 20% share surge bets everything on OpenAI
A record ¥1 trillion retail bond priced last week. Savers fund Son’s AI bet.